INVEST IN TRUBRAIN TODAY!
Offering Circular | Selected Risks Related to this Offering | TruBrain's SEC EDGAR Page
For more information on TriplePulse, Inc. (TruBrain), download and review the Offering Circular. The Offering Circular should be reviewed before making an investment decision.
.......
.......
Overview
Wearable tech can help improve how you exercise, sleep, and now.. how you think. Introducing the TruBrain wearable. The power to fight anxiety, without serious side effects - all with the click of a button.
Treat anxiety in a better, non-pharmaceutical way thanks to TruBrain. While most anxiety treatments involve Rx pills that carry side effects, our neuroscience team has built a smart wearable that conquers anxiety at the source, your brain. Built in collaboration with Tri̇di̇ Teknoloji̇ and a notable European industrial design team.
Taking the leading brand in cognitive healthcare to new heights. Join the team with $20M in sales and common investors in AirBnB and Uber.
WATCH Joe Rogan discuss Anxiety & the Brain with Dr. Andrew Hill
The Problem
.......
.....
......
.......
..........
..........
The market
Anxiety is crippling to the cognitive health of nearly 125M Americans. And that number is growing. The World Health Organization estimates that since 2020, the amount of people suffering with anxiety has increased 25% worldwide.
Large hardware technology firms often avoid the medical device category due to the compliance and scientific expertise required, leaving an opportunity for more nimble, specialized brands like TruBrain to build market share.
the solution
.......
.......
.......
Our team has spent considerable time validating our path to market. We believe that it is optimal for us to start as a Class II medical device for anxiety, versus Class III for depression. This allows us to save considerable time, money, and risk of Cranial Electrotherapy Stimulators achieving FDA Class III status.
Traction
.......
.......
.......
TruBrain customers come from all walks of life and work in nearly every profession. Members of the armed forces order TruBrain to more than 70 bases around the globe. Parents take TruBrain after a long day of work so they’ll still have energy to read to their kids and help them with their homework. Writers, producers, and artists swear by TruBrain to boost their creative process. Our customers live in over 80 countries around the world. We work to offer compelling, proactive, healthy alternatives to low-performance packaged foods and over-stimulating pharmaceuticals.
*These testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success
These testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success
At TruBrain, our focus is human performance, and our products are designed to enhance your brain's natural abilities. We bring high-performance food and beverage nutrition that delivers positive, measurable outcomes to mainstream consumers. Brainwave measurement is at the core of our origin as a company. We never claimed to be the smartest people on the planet, but we know some of the people who are – artists, surgeons, CEOs, and musicians. So we picked their brains, literally. We studied their thought patterns, their ability to handle stress, how they thought on their feet, and how they dealt with distractions. This led to the understanding of optimal brainwave patterns and the beginning of our journey to help people find their true brain.
OUR TEAM
We’re led by a visionary founder and veteran leadership with wide experience in neuroscience, healthcare, & consumer experience. Our CEO, Chris Thompson, has deep industry experience in consumer packaged goods - he managed billion dollar brands for Unilever, one of the largest CPG companies in the world. We use what we sell. Whether it is Chris testing Ketones during endurance training or Dr. Andrew Hill testing the latest neurotechnology in the EEG brain lab - we take it, we test it, we share it, we improve it. We have fostered a team whose collective efforts are all driven toward elevating the lives of our customers. Our purpose is to empower people to do their best thinking.
WHY INVEST
Our customers asked us to work on a large barrier in their way of performance - anxiety. We are so excited to attack the anxiety market with our wearable technology by top neuroscientists. We believe this will offer a compelling alternative to pharmaceuticals that have many side effects and will further our reach and status as the leading brand in cognitive healthcare.
Our mission is to make high function solutions accessible to mainstream consumers. Our products deliver a material benefit in people’s lives, and our role is to help them access these benefits. We believe the direct relationship with consumers is the most valuable component in the cognitive healthcare system, and we work to offer compelling, proactive health alternatives to low-function packaged goods and overly stimulating pharmaceuticals.
The expansion of our product portfolio to include wearables, and the ability to offer a personalized healthcare experience only furthers our standing as one of the leading brands in the space. We think that through our brand equity, technology, extensive press coverage, and market timing, we will scale to widespread acceptance.
Join us and say hello to your TruBrain.
Chris Thompson, CEO
Footnotes
[3] - https://bit.ly/36efVUe
[4] - https://www.nytimes.com/2004/10/12/business/company-news-abbott-to-acquire-eas-for-320-million.html
[10] - https://pubmed.ncbi.nlm.nih.gov/30597564/
[12] - https://www.sciencedaily.com/releases/2018/07/180710104631.htm
---
AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT.
THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT CAN BE FOUND HERE.
THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.
WHILE THE COMPANY HAS SIGNED A QUOTATION AGREEMENT TO TRADE THE SECURITIES OFFERED ON STARTENGINE SECONDARY’S NEW ALTERNATIVE TRADING SYSTEM (THE “ATS”), A COMPANY WHICH INTENDS TO BE QUOTED ON THE MARKETPLACE WILL BE SUBJECT TO CERTAIN REQUIREMENTS WHICH THE COMPANY MAY OR MAY NOT BE ABLE TO SATISFY IN A TIMELY MANNER. EVEN IF A COMPANY IS QUALIFIED TO QUOTE ITS SECURITIES ON THE MARKET, THERE IS NO GUARANTEE AN ACTIVE TRADING MARKET FOR THE SECURITIES WILL EVER DEVELOP, OR IF DEVELOPED, BE MAINTAINED. YOU SHOULD ASSUME THAT YOU MAY NOT BE ABLE TO LIQUIDATE YOUR INVESTMENT FOR SOME TIME OR BE ABLE TO PLEDGE THESE SHARES AS COLLATERAL.
TruBrain is launching wearable technology for anxiety, using established technology that has been cleared by the FDA. Anxiety Market size of $11 Billion. Designed by PhD neuroscientists and notable European industrial designers. Profitable brand with $20 million in lifetime sales. Featured in Forbes, CNBC & Bloomberg.
Maximum Number of Shares Offered subject to adjustment for bonus shares
x
05.31.23
We just crossed another milestone.. over $1.3 Million raised! With the backing of 4 VC funds and 2,000+ StartEngine investors, TruBrain has a strong investor community.
We are a profitable, venture backed company that is disrupting an $11 Billion market through the use of neuroscience and wearable technology.
Remember, every investor gets $325 worth of free product along with their shares!
Become an investor for less than $500 today!
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.30.23
There are only 15 days left to invest in TruBrain and their wearable technology that will help 125 million Americans suffering with anxiety. This is an $11 Billion market!
Don’t forget! TruBrain is profitable, with over $20 Million in sales, and has the backing of 4 Venture Capital Firms.
Invest now and get $325 worth of free product and up to a 50% lifetime discount!
Join over 2,000+ investors that have joined one of the leaders in cognitive healthcare.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.
05.25.23
There are only 20 days left to invest in TruBrain and their wearable technology that will help 125 million Americans suffering with anxiety. This is an $11 Billion market!
Don’t forget! TruBrain is profitable, with over $20 Million in sales, and has the backing of 4 Venture Capital Firms.
Invest now and get $325 worth of free product and up to a 50% lifetime discount!
Join over 2,000+ investors that have joined one of the leaders in cognitive healthcare.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.
05.24.23
There are nearly 20 anxiety drugs on the market. But many of these pharmaceutical drugs that are pushed by Big Pharma come with a whole host of debilitating side effects. That is why many people seek treatment for anxiety outside of these Big Pharma drugs. That is where TruBrain comes in. The technology in TruBrain’s new Wearable Device has been shown to be effective at treating Anxiety, without the side effects that come with pharmaceutical drugs. It’s also FDA Cleared tech!
See why customers choose Wearable Technology instead of Pharmaceuticals
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.23.23
The technology underlying TruBrain’s new Wearable Device is being studied at one of the most prestigious universities around the globe, Harvard. In a recent article, Harvard Health Publishing mentions “hype around transcranial neurostimulation is growing for an expanding list of conditions such as depression, ADHD, and even Alzheimer's disease.” In another article, by a Psychiatry Advisor, they mention the potential for neurostimulation to treat ADHD. All of these potential use cases are extremely exciting for the future. For now, the technology in TruBrain’s device is FDA Cleared for Anxiety. We’re excited about what’s on the horizon.
Learn more about the tech in Harvard's study
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.20.23
There are only 25 days left to invest in TruBrain and their wearable technology that will help 125 million Americans suffering with anxiety. This is an $11 Billion market!
Don’t forget! TruBrain is profitable, with over $20 Million in sales, and has the backing of 4 Venture Capital Firms.
Invest now and get $325 worth of free product and up to a 50% lifetime discount!
Join over 2,000+ investors that have joined one of the leaders in cognitive healthcare.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.
05.17.23
Meet Dr. Andrew Hill. One of TruBrain’s Neuroscientists from UCLA, Dr. Hill has been a featured guest of Joe Rogan, Ben Greenfield, and Dr. Drew. Dr. Hill concentrated his studies on how attention operates in the brain, which helped in developing many of the personalized formulas that we offer. He played an integral role in the development and clinical research behind our best selling Drinks as well as our suite of other cognitive healthcare products. Dr. Hill received his PhD in Cognitive Neuroscience from UCLA and lectures at UCLA on the topic of healthy brain aging.
Learn more about the team disrupting an $11 Billion market
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.15.23
This is the Final Month to invest in TruBrain! That means there are only 30 days left to get shares in the brand that is disrupting an $11 Billion market.
Don’t forget! TruBrain is profitable, with over $20 Million in sales, and has the backing of 4 Venture Capital Firms.
Invest now and get $325 worth of free product and up to a 50% lifetime discount!
Join over 2,000+ investors that have joined one of the leaders in cognitive healthcare.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.
05.09.23
TruBrain increased profits by over 90% last year and has now crossed $20 Million in lifetime revenue. TruBrain continues to make strides as one of the leaders in the cognitive healthcare space. Join our investor community today!
Join over 2000+ investors that believe in TruBrain's growth
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.04.23
TruBrain is your digital clinic for cognitive health. Our PhD neuroscientists have designed all of our products to aid everything from customers’ memory & focus to anxiety & stress. Our new wearable devices are designed to help the 125M Americans that suffer with anxiety and help to calm their brain and find new ways to unlock their full cognitive potential.
See why TruBrain is one of the leaders in cognitive healthcare
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
05.01.23
We are excited about the NBC News piece covering neurostimulation. The growing interest in cognitive enhancement suggests that people are becoming more aware of the potential of the human brain and acceptance for non-pharmaceutical solutions. As we continue to learn more about how the brain works and how we can improve its functioning, we can discover new ways to unlock our full cognitive potential. This could have far-reaching implications for everything from education and creativity to health and wellness.
Here is your opportunity to invest in this $11B market going mainstream
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Members get an extra 10% shares in addition to rewards below!
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
Tier 1
Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, and 1 TruBrain merchandise).
Tier 2
Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device).
Tier 3
30% Lifetime discount on our products. + Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device).
Tier 4
40% Lifetime discount on our products.*, 5% Bonus Shares, Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device).
Tier 5
50% Lifetime discount on our products., 10% Bonus Shares, Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device)., Beta test group.
Tier 6
50% Lifetime discount on our products, 15% Bonus Shares, Product Bundle (includes 1 Medium Capsules, 1 Extra Strength Capsules, 1 TruBrain merchandise, and 1 TruBrain wearable device), Annual conference call with TruBrain’s CEO Meeting.
0/2500
PINNED BY STARTUP
a year ago
0
0
9 hours ago
0
0
16 days ago
3
0
40 INVESTMENTS
18 days ago
1
0
2 months ago
1
0
18 INVESTMENTS
2 months ago
1
0
7 INVESTMENTS
2 months ago
1
0
3 months ago
1
0
2 INVESTMENTS
3 months ago
1
0
Cancel anytime before 48 hours before a rolling close or the offering end date.
We want you to succeed and get the most out of your money by offering rewards and memberships!
Your info is your info. We take pride in keeping it that way!
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
Important Message
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.
www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.
Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.
Investment opportunities posted and accessible through the site are of three types:
1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.
Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.
By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.
Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.
California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.
StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.
PINNED BY STARTUP
TruBrain IR
a year ago
11
1